Stay updated on Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page.

Latest updates to the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page
- Check4 days agoChange DetectedLocations section updated with new regional labels (Ge, Li) and areas (North Holland, Provincie Groningen, South Holland, Utrecht); old location blocks were removed and the revision version updated from v3.3.2 to v3.3.3.SummaryDifference0.7%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedUpdated the Publications section to indicate that PubMed entries are auto-populated and may not all pertain to the study, and updated the revision label from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the general government funding and operating-status notice from the study page. This notice previously warned that information may not be up to date during funding lapses and directed users to cc.nih.gov and opm.gov for updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedNo significant content changes were detected between the two screenshots; the page content and layout appear unchanged.SummaryDifference0.4%

- Check82 days agoChange DetectedAdd: new government-status notice and current version v3.2.0. Delete: removal of the Multiple myeloma resource reference and v3.1.0.SummaryDifference3%

- Check90 days agoChange DetectedReplace "Plasma cell myeloma" with "Multiple myeloma" and bump revision from v3.0.2 to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page.